News
Survival improved for some patients with metastatic cancers
Among patients with metastatic gastrointestinal stromal tumors, neuroendocrine tumors, melanoma, and several cancers, 5-year survival increased by...
News
Gene variants plus H. pylori increase risk of gastric cancer
The new findings imply that the hereditary contribution to the risk of gastric cancer is more important than previously believed.
News
Digital rectal exam fails as screening tool for prostate cancer
In a new study, 99% of digital rectal examinations did not raise suspicion for prostate cancer.
News
Urine test predicts future bladder cancer 12 years before symptoms
The test, if validated in further studies, has the potential to serve as a cancer screening tool for individuals at elevated risk for bladder...
News
Autoantibodies signal reduced cancer risk in dermatomyositis
In patients with dermatomyositis positive for anti–TIF1-gamma autoantibodies, the presence of anti-CCAR1 autoantibodies indicate normal rather...
News
Consider cultural differences in IBD diet planning
Clinicians should incorporate culturally sensitive discussions and recommendations into interactions with patients with inflammatory bowel disease...
News
Herbal combination tames active UC in small study
Derivatives of an intensely yellow spice and an intensely blue dye combined to resolve active ulcerative colitis in a small randomized trial.
News
Adult stem cells can heal intractable perianal Crohn’s fistulae
Many patients experienced complete healing within 3 months of a single infusion of mesenchymal stem cells.
News
Gut enzymes fingered in some 5-ASA treatment failures
Patients with inflammatory bowel disease who had three or four specific acetyltransferases in their gut microbiota had a threefold higher risk for...
News
Food additives may exacerbate IBD
Emulsifiers and thickeners added to food in processing may contribute to inflammation and changes in gut microbiota.
News
Proof lacking for dual-targeted therapy benefit in IBD
Questions remain unanswered about the effectiveness of combination biologic treatment for inflammatory bowel disease.
News
Four-gene signature linked to increased PML risk
Investigators have identified four immune-associated genes that put immunocompromised patients at risk for progressive multifocal...
News
Capivasertib/fulvestrant improves progression free survival in breast cancer
The combination of the investigational AKT inhibitor capivasertib and estrogen receptor antagonist fulvestrant, doubled progression-free survival...
News
Steep cost of surviving childhood HL: Epigenetic aging
New research found accelerated epigenetic aging in most adults who survived pediatric Hodgkin lymphoma.
News
Alloantibody registry would save lives, money
New research supports establishing a national exchange of alloantibody data, to save lives and cut costs in transfusion medicine.